Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Feb 25, 2016, after the close
10-K filed Feb 25, 2016, 56 days after period end · 0001628280-16-011728
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|---|
| Revenue | $69.32M | $197.67M | $33.56M | $10.45M |
| Net Income | -$2.50M | -$13.72M | -$11.96M | -$16.35M |
| EPS Diluted | -$0.07 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.36 |
| -$0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.